Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 39.08
+1.40 (3.72%)
Nov 10, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Earnings Call Transcripts
Fiscal Year 2025
-
2025 revenue was CNY 177m, with higher R&D spending and a narrower pre-tax loss; cash reserves reached CNY 1.548bn. The key 2026 milestone is an LBL-024 BLA submission targeted for Q3, alongside expanded clinical and BD activity.